GlassScriptPhysician profile
Jesse S Pelletier
NPI 1952440372
$13,971.24
in general payments reported to CMS, 2019-2025
32 companies · $1,916 in 2025
The $1,916 reported for 2025 was more than what 88% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $542 · 2020: $312 · 2021: $7,397 · 2022: $907 · 2023: $1,526 · 2024: $1,370 · 2025: $1,916.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,813.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,812.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyevance Pharmaceuticals LLC | $7,113.91 | 2019-2022 | |
| Oyster Point Pharma, INC. | $1,323.52 | 2022-2025 | Tyrvaya |
| Abbvie INC. | $968.01 | 2022-2025 | |
| New World Medical,INC. | $886.43 | 2022-2025 | Clearpath, Streamline, Ahmed Glaucoma Valve |
| Alcon Vision LLC | $592.21 | 2019-2025 | Clareon, Eysuvis, Argos |
| Bausch & Lomb Americas INC. | $323.36 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Mallinckrodt Hospital Products INC. | $302.03 | 2020-2025 | Acthar |
| Allergan, INC. | $268.69 | 2019-2021 | |
| Horizon Therapeutics Plc | $244.39 | 2022-2023 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $202.09 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $196.88 | 2019-2024 | Cequa |
| Aerie Pharmaceuticals, INC. | $171.15 | 2019-2021 | |
| Biotissue Holdings INC. | $164.05 | 2021-2025 | |
| Dompe US, INC. | $139.92 | 2021-2025 | Oxervate |
| Novartis Pharmaceuticals Corporation | $135.52 | 2019-2023 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $115.79 | 2024-2025 | Vevye, Iheezo |
| Sight Sciences, INC. | $108.98 | 2019-2025 | Omni Surgical System, Sion Surgical Instrument |
| Kala Pharmaceuticals, INC. | $104.78 | 2019-2021 | |
| Ani Pharmaceuticals, INC. | $94.73 | 2024-2025 | Purified Cortrophin Gel |
| Mallinckrodt Enterprises LLC | $80.66 | 2019 | |
| Alimera Sciences, INC. | $58.82 | 2024 | Iluvien, Yutiq |
| Thea Pharma INC. | $56.68 | 2022-2025 | Iyuzeh |
| Shire North American Group INC | $55.15 | 2019 | |
| Amgen INC. | $42.27 | 2025 | Tepezza |
| Tearlab Corp | $41.94 | 2023 | Tearlab Osmolarity System |
| Astellas Pharma US INC | $33.03 | 2024 | Izervay |
| Rxsight INC | $31.28 | 2023 | Rxsight Light Adjustable Lens (Rxlal), Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $28.21 | 2019 | |
| Coherus Oncology, INC. | $24.88 | 2023 | |
| Ocular Therapeutix, INC. | $24.34 | 2023 | Dextenza |
| Eyepoint US, INC. | $21.81 | 2019 | |
| Akorn, INC. | $15.73 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Pelletier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.